Codrug: An efficient approach for drug optimization

被引：84

作者：

Das, N. ^{[1
]}

Dhanawat, M. ^{[1
]}

Dash, B. ^{[1
]}

Nagarwal, R. C. ^{[1
]}

Shrivastava, S. K. ^{[1
]}

机构：

[1] Banaras Hindu Univ, Inst Technol, Dept Pharmaceut, Varanasi 221005, Uttar Pradesh, India

来源：

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2010年 / 41卷 / 05期

关键词：

Codrug; Mutual prodrug; Drug delivery; MUTUAL PRODRUG; L-DOPA; IN-VITRO; PROLIFERATIVE VITREORETINOPATHY; 5-AMINOSALICYLIC ACID; CO-DRUG; PHARMACOLOGICAL EVALUATION; TRIAMCINOLONE ACETONIDE; URSODEOXYCHOLIC ACID; PARKINSONS-DISEASE;

D O I：

10.1016/j.ejps.2010.09.014

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Codrug or mutual prodrug is an approach where various effective drugs, which are associated with some drawbacks, can be modified by attaching with other drugs of same or different categories directly or via a linkage. More appropriately one can say combining two different pharmacophores with similar or different pharmacological activities elicit synergistic action or help to target the parent drug to specific site/organ/cells respectively. This approach is commonly used to improve physicochemical, biopharmaceutical and drug delivery properties of therapeutic agents. (C) 2010 Elsevier B.V. All rights reserved.

引用

页码：571 / 588

页数：18

共 95 条

[21] PHARMACOKINETICS OF RO 23-9424, A DUAL-ACTION CEPHALOSPORIN, IN ANIMALS [J].

CHRISTENSON, JG ;

CHAN, KK ;

CLEELAND, R ;

DIXHOLZKNECHT, B ;

FARRISH, HH ;

PATEL, IH ;

SPECIAN, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1895-1900

[22] GASTRIC BLEEDING AND BENORYLATE - NEW ASPIRIN [J].

CROFT, DN ;

CUDDIGAN, JH ;

SWEETLAND, C .

BMJ-BRITISH MEDICAL JOURNAL, 1972, 3 (5826) :545-+

[23] Novel antiglaucoma prodrugs and codrugs of ethacrynic acid [J].

Cynkowska, G ;

Cynkowski, T ;

Al-Ghananeem, AA ;

Guo, H ;

Ashton, P ;

Crooks, PA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (15) :3524-3527

[24] Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease [J].

Dhaneshwar, Suneela S. ;

Gairola, Neha ;

Kandpal, Mini ;

Vadnerkar, Gaurav ;

Bhatt, Lokesh ;

Rathi, Badal ;

Kadam, S. S. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (10) :3922-3929

[25] Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats [J].

Dhaneshwar, Suneela S. ;

Chail, Mukta ;

Patil, Mahavir ;

Naqvi, Salma ;

Vadnerkar, Gaurav .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (01) :131-142

[26] L-Dopa- and dopamine-(R)-α-lipoic acid conjugates as multifunctional codrugs with antioxidant properties [J].

Di Stefano, A ;

Sozio, P ;

Cocco, A ;

Iannitelli, A ;

Santucci, E ;

Costa, M ;

Pecci, L ;

Nasuti, C ;

Cantalamessa, F ;

Pinnen, F .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (04) :1486-1493

[27]

Di Stefano A, 2009, EXPERT OPIN DRUG DEL, V6, P389, DOI [10.1517/17425240902870405, 10.1517/17425240902870405 ]

[28] Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies [J].

Foo, Jasmine ;

Michor, Franziska .

PLOS COMPUTATIONAL BIOLOGY, 2009, 5 (11)

[29] A role for the thromboxane receptor in L-NAME hypertension [J].

Francois, Helene ;

Makhanova, Natalia ;

Ruiz, Philip ;

Ellison, Jonathan ;

Mao, Lan ;

Rockman, Howard A. ;

Coffman, Thomas M. .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (04) :F1096-F1102

[30] SULTAMICILLIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].

FRIEDEL, HA ;

CAMPOLIRICHARDS, DM ;

GOA, KL .

DRUGS, 1989, 37 (04) :491-522

← 1 2 3 4 5 6 7 8 9 10 →